Barrow, Hanley, Mewhinney & Strauss
SEM

Barrow, Hanley, Mewhinney & Strauss’s Select Medical SEM Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-556
Closed -$9.06K – 424
2026
Q1 		$9.06K Sell
556
-87
-14% -$1.36K ﹤0.01% 234
2025
Q4 		$9.55K Hold
643
– – ﹤0.01% 226
2025
Q3 		$8.26K Sell
643
-167
-21% -$2.23K ﹤0.01% 231
2025
Q2 		$12.3K Buy
+810
New +$12.6K ﹤0.01% 197

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's SEM Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Select Medical (SEM) in Q2 2026, closing a stake of 556 shares — an estimated $9.06K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in SEM in Q2 2025 and held it in 4 quarters. The position peaked at $12.3K in Q2 2025. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 556 Select Medical shares in Q2 2026, an estimated $9.06K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Select Medical in Q2 2025 and held it in 4 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Select Medical position peaked at $12.3K in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.